SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2184144

Cover Image

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2184144

Hyperspectral Imaging for Surgical Tissue Assessment Market Forecasts to 2034 - Global Analysis By Component (Hardware, Software and Services), Imaging System Type, Imaging Modality, Technology, Application, End User and By Geography

PUBLISHED:
PAGES: 300+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4150
PDF (2-5 User License)
USD 5250
PDF & Excel (Site License)
USD 6350
PDF & Excel (Global Site License)
USD 7500

Add to Cart

According to Stratistics MRC, the Global Hyperspectral Imaging for Surgical Tissue Assessment Market is estimated at $0.4 billion in 2026 and is expected to reach $1.7 billion by 2034, growing at a CAGR of 19.8% during the forecast period. Hyperspectral Imaging for Surgical Tissue Assessment utilizes advanced optical imaging, spectral analysis, and artificial intelligence to evaluate tissue composition, oxygenation, perfusion, and pathological changes during surgical procedures. Increasing demand for precision surgery, growing adoption of image-guided interventions, and rising investment in advanced surgical imaging technologies are driving market growth. Technological advancements in compact hyperspectral cameras, real-time spectral processing, and AI-enabled tissue classification are improving intraoperative assessment capabilities. Expanding applications in oncology surgery, tissue viability evaluation, and vascular assessment are creating opportunities across hospitals, specialty surgical centers, and research institutions.

Market Dynamics:

Driver:

Increasing demand for precision surgery and real-time intraoperative tissue assessment

Increasing demand for precision surgery and real-time intraoperative tissue assessment is driving development of hyperspectral imaging technologies. Surgeons increasingly require non-invasive methods to evaluate tissue perfusion, oxygenation, and pathological changes during procedures. Hyperspectral imaging captures spectral information across multiple wavelengths to support tissue differentiation without necessarily requiring contrast agents. Growing surgical volumes, expanding image-guided surgery programs, and investment in advanced operating room technologies encourage adoption. Improvements in camera miniaturization and processing speed further support market development.

Restraint:

High equipment costs and challenges in surgical workflow integration

High equipment costs and challenges in surgical workflow integration restrain adoption of hyperspectral imaging for surgical tissue assessment. Advanced systems require specialized cameras, illumination components, computational hardware, and sophisticated image processing software. Large spectral datasets can increase processing requirements and complicate real-time interpretation. Differences in surgical lighting, tissue movement, and acquisition conditions affect imaging consistency. Limited reimbursement, insufficient standardized clinical protocols, and lengthy validation requirements create additional barriers to routine operating room implementation.

Opportunity:

Expansion of AI-enabled real-time hyperspectral surgical imaging

Expansion of AI-enabled real-time hyperspectral surgical imaging presents significant growth opportunities. Advanced platforms combine spectral imaging with machine learning, deep learning, and automated tissue classification to support intraoperative decision-making. Integration with endoscopic systems, robotic surgery platforms, and surgical visualization technologies could expand clinical applications. Growing investment in tumor margin identification, tissue oxygenation assessment, and vascular imaging encourages innovation. Improvements in compact sensors, spectral data processing, and real-time visualization support future commercialization.

Threat:

Limited clinical validation and competition from established surgical imaging modalities

Limited clinical validation and competition from established surgical imaging modalities pose significant challenges to hyperspectral imaging adoption. Differences in tissue characteristics, illumination conditions, and imaging algorithms can affect diagnostic reliability and reproducibility. Established technologies, including fluorescence imaging, ultrasound, and conventional surgical visualization, offer familiar alternatives. Increasing regulatory scrutiny and requirements for demonstrated clinical utility create commercialization barriers. Concerns regarding operating room integration, acquisition speed, and cost-effectiveness further complicate widespread clinical implementation.

Covid-19 Impact:

The COVID-19 pandemic disrupted elective surgical procedures, hospital equipment procurement, and clinical research activities, affecting development of hyperspectral surgical imaging technologies. Restrictions on operating room access and supply chain interruptions delayed system evaluations and installations. However, increased interest in advanced medical imaging and contactless tissue assessment supported continued research. Subsequent recovery in surgical volumes, renewed investment in operating room modernization, and expanding research into AI-assisted surgical visualization continue to support market development.

The hardware segment is expected to be the largest during the forecast period

The hardware segment is expected to account for the largest market share during the forecast period due to substantial investment in hyperspectral cameras, optical sensors, illumination systems, and image processing equipment. Surgical hyperspectral imaging requires specialized instruments capable of capturing detailed spectral information across tissue surfaces. Increasing research installations, expanding clinical evaluation programs, and growing demand for advanced intraoperative imaging encourage equipment adoption. Advances in compact camera design, optical sensitivity, and integrated imaging systems support segment growth.

The deep learning segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the deep learning segment is predicted to witness the highest growth rate due to increasing demand for automated tissue classification and real-time spectral image interpretation. Deep learning models can analyze complex spectral patterns to support tumor identification, perfusion assessment, and tissue characterization. Advances in convolutional neural networks, vision transformers, and accelerated computing improve analytical capabilities. Growing investment in AI-assisted surgery, intelligent imaging platforms, and automated intraoperative decision support is expected to accelerate adoption.

Region with largest share:

During the forecast period, North America is expected to hold the largest share due to advanced surgical infrastructure, substantial medical technology investment, and extensive research in image-guided surgery. The United States leads regional development through medical imaging companies, academic hospitals, and research institutions investigating hyperspectral surgical applications. Increasing adoption of precision surgery, established clinical research networks, and growing investment in AI-enabled imaging encourage development. Partnerships between technology manufacturers and healthcare institutions strengthen regional commercialization.

Region with highest CAGR:

Over the forecast period, Asia Pacific is anticipated to exhibit the highest CAGR, supported by expanding healthcare infrastructure, increasing surgical volumes, and growing investment in advanced medical imaging technologies. China, Japan, India, South Korea, and Australia are advancing surgical innovation and biomedical imaging research. Improving access to sophisticated imaging equipment, expanding hospital modernization programs, and increasing interest in AI-assisted surgery encourage adoption. Government healthcare investments and collaborations between medical technology companies and research institutions support regional growth.

Key players in the market

Some of the key players in the Hyperspectral Imaging for Surgical Tissue Assessment Market include Diaspective Vision GmbH, Hypervision Surgical Ltd., KARL STORZ SE & Co. KG, Quest Medical Imaging B.V., HyperMed Imaging, Inc., Headwall Photonics, Inc., Specim, Spectral Imaging Ltd., Cubert GmbH, XIMEA GmbH, Resonon Inc., BaySpec, Inc., imec, Photonfocus AG, Norsk Elektro Optikk AS, ChemImage Corporation, Teledyne DALSA, Ocean Insight, and Spectral Devices Inc.

Key Developments:

In October 2026, Specim, Spectral Imaging Ltd. launched the Specim SX10, a high-performance visible and near-infrared hyperspectral camera operating across the 400-1000 nm wavelength range. The camera combines high spatial resolution, spectral precision, and integration-ready connectivity, supporting advanced imaging research and potential development of biomedical spectral analysis applications.

In September 2026, Cubert GmbH introduced the integration of its Cuvis.AI framework with Cuvis.Next software, enabling hyperspectral data processing, machine learning model development, and live analytical visualization. The development supports automated spectral classification and could facilitate future AI-enabled tissue imaging applications, although it is not specifically a surgical product launch.

In April 2026, Hypervision Surgical Ltd. announced the successful completion of a £17.0 million Series A financing round to advance its hyperspectral surgical imaging technology. The investment supports commercialization of its HYPERSNAP surgical imaging system and further development of real-time tissue assessment and surgical intelligence capabilities.

Components Covered:

  • Hardware
  • Software
  • Services

Imaging System Types Covered:

  • Snapshot Hyperspectral Imaging Systems
  • Pushbroom Hyperspectral Imaging Systems
  • Spectral Scanning Hyperspectral Imaging Systems
  • Other Imaging System Types

Imaging Modalities Covered:

  • Visible & Near-Infrared (VNIR) Imaging
  • Short-Wave Infrared (SWIR) Imaging
  • Extended & Multiband Spectral Imaging
  • Other Imaging Modalities

Technologies Covered:

  • Spectral Unmixing & Tissue Classification
  • Machine Learning
  • Deep Learning
  • Real-Time Spectral Image Analytics
  • Hybrid AI & Statistical Models
  • Other Technologies

Applications Covered:

  • Tumor Detection & Surgical Margin Assessment
  • Tissue Perfusion & Oxygenation Assessment
  • Tissue Viability & Ischemia Assessment
  • Vascular & Microcirculation Assessment
  • Nerve & Anatomical Structure Identification
  • Tissue Differentiation & Characterization
  • Other Applications

End Users Covered:

  • Hospitals
  • Specialty Surgical Centers
  • Ambulatory Surgical Centers
  • Academic & Research Institutions
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
      • Saudi Arabia
      • United Arab Emirates
      • Qatar
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Egypt
      • Morocco
      • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Product Code: SMRC41803

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Hyperspectral Imaging for Surgical Tissue Assessment Market, By Component

  • 5.1 Hardware
    • 5.1.1 Hyperspectral Cameras & Sensors
    • 5.1.2 Illumination & Optical Components
    • 5.1.3 Image Processing & Computing Units
  • 5.2 Software
    • 5.2.1 Spectral Image Processing Software
    • 5.2.2 AI-Based Tissue Analysis Software
  • 5.3 Services
    • 5.3.1 System Integration & Implementation
    • 5.3.2 Maintenance & Technical Support

6 Global Hyperspectral Imaging for Surgical Tissue Assessment Market, By Imaging System Type

  • 6.1 Snapshot Hyperspectral Imaging Systems
  • 6.2 Pushbroom Hyperspectral Imaging Systems
  • 6.3 Spectral Scanning Hyperspectral Imaging Systems
  • 6.4 Other Imaging System Types

7 Global Hyperspectral Imaging for Surgical Tissue Assessment Market, By Imaging Modality

  • 7.1 Visible & Near-Infrared (VNIR) Imaging
  • 7.2 Short-Wave Infrared (SWIR) Imaging
  • 7.3 Extended & Multiband Spectral Imaging
  • 7.4 Other Imaging Modalities

8 Global Hyperspectral Imaging for Surgical Tissue Assessment Market, By Technology

  • 8.1 Spectral Unmixing & Tissue Classification
  • 8.2 Machine Learning
  • 8.3 Deep Learning
    • 8.3.1 Convolutional Neural Networks (CNNs)
    • 8.3.2 Vision Transformers
  • 8.4 Real-Time Spectral Image Analytics
  • 8.5 Hybrid AI & Statistical Models
  • 8.6 Other Technologies

9 Global Hyperspectral Imaging for Surgical Tissue Assessment Market, By Application

  • 9.1 Tumor Detection & Surgical Margin Assessment
  • 9.2 Tissue Perfusion & Oxygenation Assessment
  • 9.3 Tissue Viability & Ischemia Assessment
  • 9.4 Vascular & Microcirculation Assessment
  • 9.5 Nerve & Anatomical Structure Identification
  • 9.6 Tissue Differentiation & Characterization
  • 9.7 Other Applications

10 Global Hyperspectral Imaging for Surgical Tissue Assessment Market, By End User

  • 10.1 Hospitals
  • 10.2 Specialty Surgical Centers
  • 10.3 Ambulatory Surgical Centers
  • 10.4 Academic & Research Institutions
  • 10.5 Other End Users

11 Global Hyperspectral Imaging for Surgical Tissue Assessment Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Diaspective Vision GmbH
  • 14.2 Hypervision Surgical Ltd.
  • 14.3 KARL STORZ SE & Co. KG
  • 14.4 Quest Medical Imaging B.V.
  • 14.5 HyperMed Imaging, Inc.
  • 14.6 Headwall Photonics, Inc.
  • 14.7 Specim, Spectral Imaging Ltd.
  • 14.8 Cubert GmbH
  • 14.9 XIMEA GmbH
  • 14.10 Resonon Inc.
  • 14.11 BaySpec, Inc.
  • 14.12 imec
  • 14.13 Photonfocus AG
  • 14.14 Norsk Elektro Optikk AS
  • 14.15 ChemImage Corporation
  • 14.16 Teledyne DALSA
  • 14.17 Ocean Insight
  • 14.18 Spectral Devices Inc.
Product Code: SMRC41803

List of Tables

  • Table 1 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Component (2023-2034) ($MN)
  • Table 3 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Hardware (2023-2034) ($MN)
  • Table 4 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Hyperspectral Cameras & Sensors (2023-2034) ($MN)
  • Table 5 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Illumination & Optical Components (2023-2034) ($MN)
  • Table 6 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Image Processing & Computing Units (2023-2034) ($MN)
  • Table 7 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Software (2023-2034) ($MN)
  • Table 8 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Spectral Image Processing Software (2023-2034) ($MN)
  • Table 9 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By AI-Based Tissue Analysis Software (2023-2034) ($MN)
  • Table 10 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Services (2023-2034) ($MN)
  • Table 11 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By System Integration & Implementation (2023-2034) ($MN)
  • Table 12 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Maintenance & Technical Support (2023-2034) ($MN)
  • Table 13 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Imaging System Type (2023-2034) ($MN)
  • Table 14 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Snapshot Hyperspectral Imaging Systems (2023-2034) ($MN)
  • Table 15 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Pushbroom Hyperspectral Imaging Systems (2023-2034) ($MN)
  • Table 16 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Spectral Scanning Hyperspectral Imaging Systems (2023-2034) ($MN)
  • Table 17 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Other Imaging System Types (2023-2034) ($MN)
  • Table 18 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Imaging Modality (2023-2034) ($MN)
  • Table 19 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Visible & Near-Infrared (VNIR) Imaging (2023-2034) ($MN)
  • Table 20 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Short-Wave Infrared (SWIR) Imaging (2023-2034) ($MN)
  • Table 21 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Extended & Multiband Spectral Imaging (2023-2034) ($MN)
  • Table 22 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Other Imaging Modalities (2023-2034) ($MN)
  • Table 23 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Technology (2023-2034) ($MN)
  • Table 24 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Spectral Unmixing & Tissue Classification (2023-2034) ($MN)
  • Table 25 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Machine Learning (2023-2034) ($MN)
  • Table 26 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Deep Learning (2023-2034) ($MN)
  • Table 27 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Convolutional Neural Networks (CNNs) (2023-2034) ($MN)
  • Table 28 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Vision Transformers (2023-2034) ($MN)
  • Table 29 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Real-Time Spectral Image Analytics (2023-2034) ($MN)
  • Table 30 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Hybrid AI & Statistical Models (2023-2034) ($MN)
  • Table 31 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 32 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Application (2023-2034) ($MN)
  • Table 33 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Tumor Detection & Surgical Margin Assessment (2023-2034) ($MN)
  • Table 34 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Tissue Perfusion & Oxygenation Assessment (2023-2034) ($MN)
  • Table 35 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Tissue Viability & Ischemia Assessment (2023-2034) ($MN)
  • Table 36 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Vascular & Microcirculation Assessment (2023-2034) ($MN)
  • Table 37 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Nerve & Anatomical Structure Identification (2023-2034) ($MN)
  • Table 38 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Tissue Differentiation & Characterization (2023-2034) ($MN)
  • Table 39 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 40 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By End User (2023-2034) ($MN)
  • Table 41 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 42 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Specialty Surgical Centers (2023-2034) ($MN)
  • Table 43 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 44 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Academic & Research Institutions (2023-2034) ($MN)
  • Table 45 Global Hyperspectral Imaging for Surgical Tissue Assessment Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!